OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales
Crossref DOI link: https://doi.org/10.1007/s10198-015-0737-2
Published Online: 2015-10-19
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Freemantle, Nick
Khalaf, Kristin
Loveman, Clara
Stanisic, Sanja
Gultyaev, Dmitry
Lister, Johanna
Drake, Marcus
License valid from 2015-10-19